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IgG4-related sclerosing disease clinically mimicking oral squamous
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IgG4-related sclerosing disease is a distinct clinicopathologic entity known to involve the maxillofacial region,
particularly the salivary, lacrimal, and pituitary glands. We report a case with lesions involving the tongue and palatine tonsil
with associated skin lesions. A 45-year-old female patient presented with a history of soreness, dysphagia, and an
asymptomatic rash involving the upper trunk. The initial clinical diagnosis of her oral lesions was squamous cell carcinoma.
The diagnosis of an IgG4-related lesion was confirmed by histologic examination of the oral and skin lesions as well as
confirmation of raised serum IgG4 levels. Tapering systemic corticosteroid therapy resulted in complete resolution of the
lesions. This is the first report of IgG4-related sclerosing disease presenting as concurrent oral and skin lesions, with the oral
lesion clinically resembling oral squamous cell carcinoma. Such lesions present a diagnostic challenge, but the outcome is
very favorable. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;xx:xxx)
CASE REPORT
A 45-year-old female patient was referred by her medical
practitioner to the local maxillofacial surgery unit because of
a 4-month history of gradually worsening pain and soreness
involving the left side of the tongue with associated dyspha-
gia. She also had a widespread skin rash which presented at
the same time as her oral symptoms. The patient had a history
of poorly controlled type II diabetes, which was being man-
aged with metformin as well as insulin. She also suffered
from hypertension and asthma and was allergic to penicillin.
The patient was a heavy smoker but reported minimal alcohol
intake.
On examination, a 3.0  1.5 cm tender, indurated, speckled
patch with a nodular surface and raised margins involving the
left lateral border and dorsum of tongue was seen (Figure 1).
In addition, a similar lesion involving the right tonsillar
region and palpable lymph nodes bilaterally involving level II
of the neck were also noted. Extraoral examination showed an
asymptomatic psoriatic rash of the same vintage as the oral
lesions involving the patient’s chest, arms, and legs, which
had not been treated previously.
INVESTIGATIONS
Initial hematologic investigations showed slightly
raised white cell, neutrophil, and platelet counts of
17.8  109/L, 11.7  109/L, and 511  109/L,
respectively (normal ranges 4-11  109/L, 2.5-7.5 
109/L, and 150-400  109/L, respectively) with a
low mean corpuscular volume of 72.7 fL (normal
range 76-96 fL) and a ferritin level of 12 ng/mL
(normal range 15-200 ng/mL). Magnetic resonance
imaging (MRI), an orthopantomogram, and a chest
x-ray were ordered for clinical staging, and inci-
sional biopsies of the tongue and tonsillar lesions
were scheduled to obtain a tissue diagnosis.
The orthopantomogram and the chest x-ray did not
reveal any abnormality. No obvious tongue or tonsillar
lesions were identified on the MRI study, and the
clinically enlarged bilateral neck lymph nodes were
judged to be reactive rather than suggestive of a ma-
lignant process.
Incisional biopsies of the tongue and tonsillar lesions
showed similar features with a nodular surface archi-
tecture (Figure 2). The epithelium was markedly hy-
perplastic and focally hyperparakeratinized with exten-
sive neutrophil infiltration but no evidence of fungal
infection (Figures 2 and 3, A). Long and narrow epi-
thelial rete processes extended into the lamina propria,
the latter containing a dense inflammatory infiltrate
dominated by plasma cells, but also containing macro-
phages and lymphocytes. The initial impression was
that of plasma cell mucositis, and further investigations
were carried out to characterize the inflammatory infil-
trate and distinguish whether the lesion was neoplastic
(i.e., multiple myeloma, extramedullary plasmacytoma)
or reactive.1 In situ hybridization confirmed the poly-
clonal nature of the infiltrate, and immunohistochemis-
try demonstrated expression of CD3 (Figure 3, B),
CD79a (Figure 3, C), CD138, and MUM1 (results not
shown), with no expression of CD56 and cyclin-D1
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(results not shown). The Ki-67 proliferation fraction
exceeded 10% (Figure 3, D). These results confirmed
the predominantly plasmacytic and reactive nature of
the lesion. However, the site of the lesion, the lack of
symptoms involving other oral sites, and the coincident
skin lesions excluded plasma cell gingivitis, indicating
a consideration for IgG4-related sclerosing disease.
Immunohistochemistry revealed a ratio of IgG4-
(Figure 3, E) to total IgG (Figure 3, F)–expressing cells
of 65%. A literature search indicated varying degrees of
fibrosis associated with IgG4-related sclerosing disease
ranging from mild to severe depending on the stage of
the lesion, with long standing lesions tending to show
more fibrosis than the early ones.2 Based on these
findings and the diagnostic criteria recommended by
Cheuk and Chan,3 a histologic diagnosis of IgG4-re-
lated disease was made, which was later confirmed by
raised serum IgG4 levels of 3.52 g/L (normal range
0.08-1.40 g/L). Biopsy of one of the cutaneous lesions
showed a prominent and predominantly plasmacytic
infiltrate within the dermis with no evidence of vascu-
litis, in keeping with the oral diagnosis.
MANAGEMENT
Tapering steroid therapy was commenced in liaison
with the patient’s diabetes management team in con-
sideration of the medical history of diabetes. The pa-
tient was started on 10 mg daily dexamethasone which
was reduced to 6 mg after a week. After 2 weeks, the
dexamethasone was replaced by 5 mg prednisolone for
a month followed by hydrocortisone pellets as the
symptoms gradually resolved.
The treatment resulted in complete resolution of the
oral and tonsillar lesions and associated symptoms
within 2 months, with a marked reduction in skin
lesions. The complaint of dysphagia was also resolved,
and serum IgG4 levels returned to normal. The patient
has been undergoing regular clinical reviews and so far
has not experienced any recurrences.
DISCUSSION
IgG4-related sclerosing disease was first described in
the context of pancreatitis by Sarles et al. in 1961,4 and
the autoimmune nature of the disease was proposed by
Yoshida et al. in 1995.5 Most of the initial studies
focused on pancreatic manifestations, with the multior-
gan involvement discovered later.6 Furthermore, the
diagnostic levels for serum IgG4 concentration were
Fig. 1. A, An erythematous, indurated, and irregular lesion involving the midline and left dorsum of the tongue extending
posteriorly, as seen on clinical examination. B, Lateral view of the tongue, showing the lesion extending into the left lateral tongue
border and encroaching on the ventral surface.
Fig. 2. Hematoxylin and eosin staining of the tongue lesion,
showing a nodular surface architecture with hyperplastic ep-
ithelium overlying heavily inflamed connective tissue.
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not fully established until 2001.7 In the head and neck
region, IgG4-related sclerosing disease has been re-
ferred to as “Kuttner tumor” (chronic sclerosing sia-
loadenitis) and has been known to involve salivary,
lacrimal, and pituitary glands with a variable degree of
fibrosis or sclerosis depending on the stage of the
disease.8 In addition to simultaneous involvement of
multiple organs, the disease is characterized by fibrosis
and sclerosis in association with a distinct and exten-
sive IgG4-secreting lymphoplasmacytic cell infiltrate.
In normal conditions, IgG4 is the least abundant mem-
ber of the IgG family and in the normal population
accounts for 6% of the total serum IgG. The current
diagnostic criteria include elevated serum IgG4 level
coupled with increased IgG4-expressing cells within
the involved tissues (50 positive cells per high-power
field, with an IgG4/IgG ratio of 40%), in addition to
variable sclerosis with possible degeneration of the
associated structures.3 IgG4-relared sclerosing disease
typically involves men from 50 to 70 years of age.
Pancreatic malignancy arising in a background of
IgG4-related disease has been reported by multiple
groups.9-11 Recent reports have shown destructive IgG4
lesions involving the maxillary sinus12 and nasal sep-
tum,13 both of which resolved after treatment with
systemic corticosteroids. Gill et al. reported salivary
duct carcinoma arising in IgG4-related fibrosclerosis
involving the parotid gland.14 In bullous pemphigoid,
Fig. 3. Histologic sections from incisional biopsy of tongue lesion showing hematoxylin and eosin and immunohistochemical
staining. A, A dense inflammatory infiltrate was seen in the connective tissue. Immunohistochemical analysis of the infiltrate with
positive staining for (B) CD3 and (C) CD138. D, The Ki-67 proliferation fraction was 10%. The ratio of (E) IgG4- to (F) total
IgG-expressing cells was 65%.
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IgG4 has been shown to be the most abundant IgG
subclass within the oral lesions as well as circulating
within the serum and urine.15-17 In addition, IgG4 is the
predominant serum antibody in pemphigus,16 epider-
molysis bullosa acquisita,18 and herpes/pemphigoides
gestationis,19 with serum levels reflecting disease ac-
tivity. The precise cause of IgG4 overexpression in
these conditions is not known, with genetic factors,
continued antigenic stimulation, and an isotype shift
from the inflammatory IgG1 subclass to a noninflam-
matory IgG4 subclass being suggested as possible fac-
tors.15,20 However, other than the increased IgG4 pro-
duction, the disease process in these pathologic entities
markedly differs from IgG4-related sclerosing disease,
with no evidence of fibrosis or sclerosis and the lack of
a plasma cell–dominated tissue infiltrate.
To our knowledge, there have been no previous
reports of IgG4-related sclerosing disease presenting as
concurrent oral and skin lesions with clinical resem-
blance to oral squamous cell carcinoma (OSCC). Inclu-
sion of IgG4-related sclerosing disease in the differen-
tial diagnosis of any atypical inflammatory oral lesions
that clinically resemble OSCC should be considered to
reduce the need for surgical intervention. Histologic
interpretation can be difficult, because features similar
to plasma cell mucositis are seen in a number of neo-
plastic and reactive conditions, including multiple my-
eloma, extramedullary plasmacytoma, and plasma cell
gingivitis.1 Diagnosis requires thorough hematoxylin
and eosin examination, an appropriate panel of immu-
nohistochemistry markers, and consideration of associ-
ated clinical features. Once diagnosed, the clinical out-
comes can be quite favorable, with complete resolution
following steroid therapy. However, surgery might be
inevitable in patients with long-standing lesions and
resulting extensive fibrosis.
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